A randomized controlled trial of 120 brain tumor patients shows that a nurse-led multimodal rehabilitation program significantly improves swallowing function...
A LightGBM-based machine learning model predicts 28-day mortality in critically ill colorectal cancer patients, achieving strong internal performance while exposing...
A new MD Anderson study finds that pre-existing immune rejection and the intrinsic fitness of donor-derived CAR T cells determine...
A Swedish study found that intensively treated acute myeloid leukemia patients managed at home through a hospital-at-home program spent half...
A BMC Cancer study fused a routine blood-based inflammation index with age, smoking history, and AJCC stage to build a...
A phase 2 trial found that ultra-low-dose radiation therapy delivered in one or two sessions relieved painful bone lesions in...
When a person receives a cancer diagnosis, the first questions are usually about survival, treatment options, and prognosis. But for...
Scirrhous gastric cancer is among the most feared forms of stomach malignancy, distinguished by rapid infiltration of cancer cells through...
An NRG Oncology SPPORT trial analysis found that Luminal B prostate tumors identified by the PAM50 genomic classifier predicted a...
A two-year implementation study at a major children's cancer center shows that universal psychosocial screening across the pediatric cancer treatment...
A new study identifies RRM2 as a gene that connects nucleotide metabolism and SREBP1/FASN-driven lipid remodeling to gemcitabine resistance in...
Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule achieved biochemical control and...
A systematic review of 88 studies covering 29,256 people with prostate cancer maps preferences for digital supportive care, finding that...
A retrospective study of 168 patients links higher non-perfused volume ratio after HIFU ablation of uterine fibroids to greater symptom...
UChicago Medicine has launched a first-of-its-kind investigator-initiated clinical trial of a fully on-site manufactured T-cell receptor therapy engineered to target...
Hepatocellular carcinoma, the most common form of primary liver cancer, remains one of the deadliest malignancies worldwide, with prognosis poor...
Brentuximab vedotin has transformed the outlook for patients with CD30-positive lymphomas, but the antibody-drug conjugate carries a neurological price that...
A prospective analysis of nearly 500,000 participants in the HUNT Study and UK Biobank finds that higher levels of several...
A nationwide U.S. insurance claims analysis presented at the ASTRO Annual Meeting found that fewer than 30 percent of early-stage...
A short isoform of the BRD4 protein helps gastric cancer cells resist ferroptotic cell death by sustaining glutathione production, thereby...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.